Cognito collects $73M for light-and-sound Alzheimer's therapy

Mar 22, 2023 · Cognito beams up $73M for study of light-and-sound neuromod therapy to treat Alzheimer's. Riding high on early clinical trial results showing that its neuromodulation headset …

CouponFollow Extension

$73
OFF

Cognito Collects $73M For Light-and-sound Alzheimer's Therapy

6 days from now

Mar 22, 2023 · Cognito beams up $73M for study of light-and-sound neuromod therapy to treat Alzheimer's. Riding high on early clinical trial results showing that its neuromodulation headset …

fiercebiotech.com

$73
OFF

Cognito Beams Up $73M For Study Of Light-and-sound Neuromod …

6 days from now

May 8, 2023 · The series B round adds $73 million to Cognito’s coffers, the startup announced Wednesday. It’ll go toward the ongoing pivotal study of the noninvasive headset, which relies …

biotech-insider.com

$73
OFF

Can Light And Sound Therapy Treat Alzheimer’s Disease? Part 3

6 days from now

Nov 19, 2023 · Cognito Therapeutics, an MIT-based neurotechnology company, made headlines this year when they announced a $73 million investment into a premier therapy for Alzheimer’s.

forbes.com

$44000
OFF

Cognito Highlights Cost-effectiveness Of Neuromod For Alzheimer's

6 days from now

3 days ago · Cognito said findings included cost-effectiveness at an acquisition cost ranging from $44,000 to $108,000, based on various efficacy scenarios and a $100,000 willingness-to-pay …

massdevice.com

FAQs about Cognito collects $73M for light-and-sound Alzheimer's therapy Coupon?

Can Cognito help Alzheimer's patients?

In the study, patients with Alzheimer’s were tasked with using Cognito’s neuromodulation headset for an hour each day for the entire six-month study period. The headset delivers flashing, gamma-frequency light and sounds through a connected pair of glasses and headphones. ...

Can a Cognito Sham device slow Alzheimer's?

Cognito thinks its device could slow the cognitive decline that comes with the disease by strengthening and synchronizing these connections. The company’s study included 74 participants with mild to moderate Alzheimer’s who received either the Cognito stimulation or a sham device that acted as a placebo. ...

Who is Cognito Therapeutics?

Cognito Therapeutics, an MIT-based neurotechnology company, made headlines this year when they announced a $73 million investment into a premier therapy for Alzheimer’s. ...

Could Cognito Therapeutics slow Alzheimer's disease progression?

Cognito Therapeutics, a neurotechnology company birthed out of MIT, is pioneering breakthrough technology that may be able to slow the progression of Alzheimer’s disease. ...

How does Cognito work?

But if it works, it would be totally different from anything else we have in the field.” Cognito’s headset, dubbed Spectris, delivers flashing lights and sounds through a pair of connected glasses and headphones to stimulate gamma waves in the brain. Different types of brain waves have different paces, or frequencies. ...

What is Cognito therapeutic's neurostimulation device?

Cognito Therapeutic ’s neurostimulation device — a next-generation digital therapeutic designed to treat memory and cognition symptoms in Alzheimer’s disease — has been granted a breakthrough device designation by the U.S. Food and Drug Administration (FDA). ...